Sotex may expand its portfolio of drugs for rheumatology

0
415

A significant event for the Russian medical community – the XXII Russian School of Rheumatologists was held on March 23-25 in Moscow. Sotex, a pharmaceutical company based in Russia, is dedicated to using cutting-edge technologies in the development of effective and safe drugs for patients, have visited the event.

Healthcare professionals, such as rheumatologists and neurologists, have a high demand for the company’s medications. Sotex is committed to broadening its range of medicines to include those for rheumatology. The company offers solutions for the treatment of rheumatological diseases, always relying on the opinion and experience of the scientific community.

The School of Rheumatology strives to enhance professional skills and expertise in the field of rheumatology through continuous medical education. Traditionally, the event addresses novel methods for classifying rheumatic diseases, differential diagnosis, as well as contemporary principles for treating patients who have rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematous, and other related conditions.